- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT05327543
Влияние йоги на качество жизни больных раком молочной железы
Effects of Two Different Online Yoga Interventions on the Quality of Life of Breast Cancer Patients Compared With Waiting List - a Three-arm Randomized Controlled Trial
This study investigates the effects of two different online yoga interventions on the health-related quality of life in breast cancer patients. Qualitative and quantitative data will be collected.
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
In this randomized controlled trial breast cancer patients will be randomized into three treatment arms:
- Intervention group 1 will receive an Iyengar yoga intervention online in a group setting, based on the internationally renowned yoga school of B.K.S. Iyengar, which in the context of this study mainly includes physical and relaxation exercises.
- Intervention group 2 will receive a meditative yoga intervention online including physical and meditation exercises and also ideologically neutral explanations of the ethical aspects of yoga.
- Group 3 consists of a waiting list control group, combined with the offer to participate in a yoga intervention after 6 months.
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
State of Berlin
-
Berlin, State of Berlin, Германия, 14109
- Рекрутинг
- Charite University
-
Контакт:
- Miriam Roesner
- Номер телефона: 030 80505 682
- Электронная почта: m.roesner@immanuel.de
-
Главный следователь:
- Andreas Michalsen, Prof.Dr.
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Histologically confirmed diagnosis of non-metastatic breast cancer (TNM stage I-III) up to 5 years after diagnosis
- Primary therapy completed for at least 3 months
- Limitation of the quality of life due to the cancer (indication of at least 4 out of 10 points on the numerical analogue scale)
- Willingness to participate in the study and signed informed consent.
Exclusion Criteria:
- Current or planned chemotherapy, radiation or surgery
- Severe physical or psychopharmacologically treated psychiatric comorbidity due to which a patient is unable to participate in the study
- Pregnancy/breastfeeding
- Participation in other clinical trials with behavioral, psychological, or complementary medicine interventions
- Immobility or limitation for gymnastic exercise due to orthopedic, neurologic, or other medical cause
- regular meditation practice >2x/month
- regular yoga practice >2x/month
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Iyengar yoga
Intervention group 1 receives an Iyengar yoga intervention online in a group setting, based on the internationally renowned yoga school of B.K.S. Iyengar, which in the context of this study primarily includes physical and relaxation exercises. |
Iyengar Yoga focuses on the correct alignment of the body while practicing the physical exercises of yoga. Props are used to support the body in finding the right alignment. Relaxation is also part of this intervention. Participiants receive 1x90 min guided yoga class per week for 8 weeks and are encouraged to continue their practice at home daily for at least 30 minutes. |
|
Экспериментальный: Meditative yoga
Intervention group 2 receives an Integrative yoga intervention online including physical and meditation exercises as well as ideologically neutral explanations of the ethical aspects of Yoga. |
Meditative Yoga in the context of this study means practicing the physical exercises of yoga as well as meditation. Additionally, each week one of the yamas/niyamas, which are ethical principles to live by in the Yoga philosophy, will be presented at the beginning of each class and will form the theme of the class. Participants receive 1x90 min guided yoga class per week for 8 weeks and are encouraged to continue their practice at home daily for at least 30 minutes. |
|
Без вмешательства: Waitlist Control Group
Group 3 consists of a waitlist control group. Participants will be offered the opportunity to attend a yoga intervention after 4 months. The patients in this waiting list control group are allowed to choose the yoga course after 6 months. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
Временное ограничение: Date of inclusion (baseline), after 8 weeks
|
Assessing full scale, range 0-40, higher score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Assessing full scale, range 0-40, higher score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Functional Assessment of Cancer Therapy: Fatigue (FACIT-F)
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Assessing full scale, range 0-52, higher score meaning a better outcom |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Perceived Stress Scale (PSS-10)
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Assessing full scale, range 0-40, lower score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Flourishing Scale (FS-D)
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Assessing full scale, range 8-56, higher score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Self-Compassion Scale (SCS-D)
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Mean score of 12 items, range 1-5, higher score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Self-Efficacy Scale (ASKU)
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Mean score of 3 items, range 1-5, higher score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Sociodemographic measures
Временное ограничение: Date of inclusion (baseline)
|
Age, education level, personal income, household income, employment status, job description, marital status, household members, days of sick leave past 3 months |
Date of inclusion (baseline)
|
|
Behavioral questions: cigarettes
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Number of cigarettes on average per day in the last month |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Behavioral questions: alcohol
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Number of alcoholic beverages on average per week in the last month |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Expectation question
Временное ограничение: Date of inclusion (baseline)
|
expectation of effectiveness of the intervention on a 5-point likert scale, how they expect to handle the intervention on a 5-point likert scale, higher score meaning better outcome |
Date of inclusion (baseline)
|
|
Behavioural question
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
diet |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Behavioural question 2
Временное ограничение: Date of inclusion (baseline)
|
Practice of other mindfulness practices besides Yoga |
Date of inclusion (baseline)
|
|
Behavioural question 3
Временное ограничение: Date of inclusion (baseline)
|
Yoga styles were practiced before |
Date of inclusion (baseline)
|
|
Behavioural question 4
Временное ограничение: Date of inclusion (baseline)
|
If and how often yoga is practiced regularly |
Date of inclusion (baseline)
|
|
Functional Assessment of Cancer Therapy - General (FACT-G)
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Assessing full scale, range 0-108, higher score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Yama/Niyama Questionnaire - YaNiQ
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Assessing full scale, range 0-100, higher score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
|
Hospital Anxiety and Depression Scale (HADS)
Временное ограничение: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Assessing full scale, range 0-42, lower score meaning a better outcome |
Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
|
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Qualitative interviews
Временное ограничение: 8 weeks after inclusion
|
Qualitative assessment will be carried out in qualitative interviews in 20 patients participating in the study. The interviews will be recorded, transcribed and analyzed with qualitative content analysis. |
8 weeks after inclusion
|
|
Heart Rate Variability (HRV)
Временное ограничение: Date of inclusion (baseline), after 8 weeks
|
24h measuring by Faros 180 |
Date of inclusion (baseline), after 8 weeks
|
Соавторы и исследователи
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- YOMA
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .